AMD vs. Broadcom: The Better AI-Chip Stock to Buy After the Sell-Off

The market is still treating “AI semis” as one trade, but the selloff is widening the gap between businesses that merely participate in the buildout and those that monetize it with pricing power and capital returns. AVGO looks better positioned on risk-adjusted compounding: its design-win model embeds customers deeper, its software cash flows buffer hardware cyclicality, and its buybacks/dividend create a floor when multiples compress. AMD has more torque to upside if its accelerator ramp surprises, but the stock now carries a much higher dependency on flawless execution and sustained hyperscaler capex.

Second-order, the real beneficiary of custom silicon adoption is not just AVGO; it is also the cloud operators who can lower unit compute cost and keep more margin in-house. That can pressure merchant GPU/accelerator ecosystems over time if training/inference workloads shift toward bespoke chips, a modest negative for NVDA/AMD mix and a positive for networking and interconnect content. Near term, the key risk is lumpy customer timing: one delayed platform decision can hit AVGO sentiment for a quarter or two, while AMD’s multiple can re-rate down quickly if MI450 adoption or software traction slips.

The contrarian read is that investors may be over-penalizing AVGO’s concentration risk while underestimating how much of AMD’s future growth is already capitalized. In other words, the cheaper stock is not necessarily the safer one, but the market may still be paying too much for AMD’s optionality. The thesis breaks if AMD forces upward estimate revisions over the next 1-2 quarters or if AVGO’s AI revenue growth slows materially as customer digestion replaces incremental demand.